Comparison of postoperative awakening between ciprofol and propofol in elderly patients undergoing hip replacement surgery: a single-blind, randomized, controlled trial

被引:0
作者
Yang, Dawei [1 ]
Zhou, Jie [2 ]
Sun, Luyu [1 ]
Li, Min [1 ]
Zhang, Jianyou [1 ]
机构
[1] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China
[2] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Obstet & Gynecol, Yangzhou, Jiangsu, Peoples R China
关键词
Aged; Arthroplasty; replacement; hip; Postoperative period; GENERAL-ANESTHESIA; INDUCTION; MAINTENANCE; MULTICENTER; EFFICACY; PHASE-3; SAFETY;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: The aim of this paper was to compare the impact of continuous infusion of ciprofol versus propofol on postoperative awakening in elderly patients following hip replacement surgery. METHODS: Patients were randomized into two groups (N.45 each): the ciprofol group and the propofol group. The ciprofol group received ciprofol for anesthesia induction and maintenance, while the propofol group underwent anesthesia induction and maintenance using propofol. The primary outcome was awakening time. Secondary outcomes included spontaneous breathing recovery time, extubation time, time to modified Aldrete Score >9, modified observer's assessment of alertness/sedation (MOAA/S) scores, anesthetic dosage, volume of fluid replacement, urine output and administration of vasoactive drugs. RESULTS: The Ciprofol group exhibited a significantly prolonged awakening time (11.0 +/- 6.4 min vs. 7.4 +/- 4.3 min, P=0.003), spontaneous breathing recovery time (9.9 +/- 6.3 min vs. 5.9 +/- 4.3 min, P=0.001), and extubation time (12.0 [8.016.0] min vs. 8.5 [6.0-11.0] min, P=0.005), and reduced requirement for intraoperative fluid replacement (728.9 +/- 254.2 mL vs. 908.3 +/- 287.5 mL, P=0.003), increased urine output (235.1 +/- 102.1 mL vs. 173.5 +/- 106.2 mL, P=0.007), decreased likelihood of vasoactive drug administration (15/30 vs. 28/14, P=0.002). No significant differences were observed between the two groups in terms of reaching a modified Aldrete Score >9, MOAA/S scores at 0, 5, 15, or 30 minutes post-extubation, or occurrence of adverse reactions (P>0.05). The dosage of remifentanil was significantly higher in the ciprofol group [5.4 (2.7-7.4) mu gkg(-1)h(-1) vs. 3.4 (1.9-4.3) mu gkg(-1)h(-1), P0.004], with a mean maintenance dose of ciprofol at 0.8 mgkg(-1)h(-1) (range: 0.5 to 1.2 mgkg(-1)h(-1)). CONCLUSIONS: Compared to propofol, the administration of ciprofol in elderly patients following hip replacement surgery is associated with prolonged awakening time, spontaneous breathing recovery time, and extubation. The average intravenous maintenance dosage of ciprofol in geriatric patients under general anesthesia was 0.8 mgkg(-1)h(-1).
引用
收藏
页码:1074 / 1081
页数:8
相关论文
共 20 条
  • [1] The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study
    Chen, Ben-zhen
    Yin, Xin-yu
    Jiang, Li-hua
    Liu, Jin-hui
    Shi, Yan-yan
    Yuan, Bi-ying
    [J]. BMC ANESTHESIOLOGY, 2022, 22 (01)
  • [2] Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery A randomised controlled pilot trial
    Ding, Yun-ying
    Long, Yu-qin
    Yang, Hao-tian
    Zhuang, Kai
    Ji, Fu-hai
    Peng, Ke
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2022, 39 (12) : 960 - 963
  • [3] Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial
    Doi, Matsuyuki
    Morita, Kiyoshi
    Takeda, Junzo
    Sakamoto, Atsuhiro
    Yamakage, Michiaki
    Suzuki, Toshiyasu
    [J]. JOURNAL OF ANESTHESIA, 2020, 34 (04) : 543 - 553
  • [4] Gan TJ, 2024, Compare son of the Etheary of HSK3486 and Propatol for Indsetion of General Anesthesia in Adults: A Multicenter, Randomized, Double-blud, Controlled, Phase 3 Nomakenonty Tnal Anes thestology, V140, P600
  • [5] Hydrothermal Synthesis of Nanomaterials
    Gan, Yong X.
    Jayatissa, Ahalapitiya H.
    Yu, Zhen
    Chen, Xi
    Li, Mingheng
    [J]. JOURNAL OF NANOMATERIALS, 2020, 2020
  • [6] A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation
    Hung, Kuo-Chuan
    Chen, Jen-Yin
    Wu, Shao-Chun
    Huang, Po-Yu
    Wu, Jheng-Yan
    Liu, Ting-Hui
    Liu, Chien-Cheng
    Chen, I-Wen
    Sun, Cheuk-Kwan
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly
    Li, Xiaojiao
    Yang, Deming
    Li, Qianqian
    Wang, Hong
    Wang, Meng
    Yan, Pangke
    Wu, Nan
    Li, Fangqiong
    Ma, Shiping
    Ding, Yanhua
    Liu, Jingrui
    Wang, Hushan
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial
    Liang, Peng
    Dai, Meng
    Wang, Xiao
    Wang, Dongxin
    Yang, Mengchang
    Lin, Xuemei
    Zou, Xiaohua
    Jiang, Ke
    Li, Yalan
    Wang, Liangrong
    Shangguan, Wangning
    Ren, Jinghua
    He, Hefan
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2023, 40 (06) : 399 - 406
  • [9] Liv L., 2024, J Clin Apeath, V92
  • [10] Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study
    Luo, Zhen
    Tu, Hong
    Zhang, Xiang
    Wang, Xiao
    Ouyang, Wen
    Wei, Xinchuan
    Zou, Xiaohua
    Zhu, Zhaoqiong
    Li, Yalan
    Shangguan, Wangning
    Wu, Hui
    Wang, Yaping
    Guo, Qulian
    [J]. CNS DRUGS, 2022, 36 (03) : 301 - 313